You searched for united kingdom - Page 34 of 55

News and Trends 11 Nov 2022

Program management support: accelerating growth for early stage biotechs

More academic groups, new start-ups, biotechs and small pharma companies are turning to external consultants for professional program management support and guidance to help them progress their ideas into medicines…

November 11, 2022 - 6 minutesmins - By External Contributor

Interview 23 Jan 2023

Watch: pHion Therapeutics talks about next-generation mRNA vaccines

pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic and prophylactic vaccines focussed on viral infections and oncology. The company’s proprietary RALA platform can…

January 23, 2023 - 1 minutemin - By Jim Cornall

Cell Medica Catapult Therapy TCR Acquisition

News and Trends 21 Jun 2017

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

Cell Medica just acquired Catapult Therapy TCR, set up by UK’s CGT Catapult, gaining the rights to its TCR therapy candidate to treat solid tumors. Cell Medica says it’s all…

June 21, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 12 May 2023

5 highlights at first Genomics and Precision Medicine Expo

Genomics and Precision Medicine Expo – taking place on May 23 and 24 2023 at ExCeL London – has announced its top 5 highlights for this year’s inaugural conference. The…

May 12, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off…

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

Acacia Pharma Phase III Post Operative Nausea

More News! 13 Feb 2017

To the Rescue: A Final Phase III Success for Post-Operative Nausea

The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after succeeding in a final phase III study. Acacia…

February 13, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 12 Feb 2016

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a platform that can be used to improve and automate genome interpretation as part…

February 12, 2016 - 2 minutesmins - By Dani Bancroft

Anastasiia Slynko biotech investment 744x368 1

In Depth 11 Oct 2022

The biggest private biotech investments in September 2022

October 12th 2022: Article updated to remove incorrect Pharnext funding round from the text. The companies Acelyrin, InnovaFeed and Arsenal Biosciences bagged the biggest biotech investments in September 2022, with…

October 11, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Sep 2017

Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug

A study of Verona’s combination therapy for COPD observed a clinical improvement in lung function and faster onset-of-action. Verona filed for its US IPO and dosed the first patient in…

September 7, 2017 - 2 minutesmins - By Alex Dale

In Depth 25 Mar 2019

Where Does Brexit Leave European Biotech?

In the next couple of months, the UK will officially exit the EU, in a move that is popularly known as Brexit. With this date fast approaching, companies, organizations and…

March 25, 2019 - 9 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 1 Aug 2018

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

ReViral will dedicate the funds to run two clinical trials to test whether its antiviral can help patients at high risk from RSV infections. The respiratory syncytial virus (RSV) only…

August 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

celixir rnai silencing cancer colon breast

News and Trends 14 May 2019

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are…

May 14, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

Program management support: accelerating growth for early stage biotechs

Watch: pHion Therapeutics talks about next-generation mRNA vaccines

British Biotech Tops up its Cancer Pipeline with New TCR Therapy

5 highlights at first Genomics and Precision Medicine Expo

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

To the Rescue: A Final Phase III Success for Post-Operative Nausea

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

The biggest private biotech investments in September 2022

Verona Achieves Successful Results for Phase IIa Trial of Deadly Lung Disease Drug

Where Does Brexit Leave European Biotech?

London Biotech Raises €47M to Develop First Treatment Against RSV Virus

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!